Thirty-five states filed an antitrust lawsuit alleging that British drugmaker Indivior tried to keep cheaper, generic versions of Suboxone off the market. The complaint also names New Jersey's MonoSol Rx, a pharmaceutical dissolving-film company, for conspiring to corner the market on the popular medication used to treat people hooked on heroin and other painkillers.